Regal Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $966K | Buy |
2,171
+366
| +20% | +$163K | 0.07% | 242 |
|
|
2025
Q1 | $875K | Buy |
1,805
+4
| +0.2% | +$1.94K | 0.07% | 239 |
|
|
2024
Q4 | $725K | Sell |
1,801
-177
| -9% | -$71.3K | 0.05% | 270 |
|
|
2024
Q3 | $920K | Sell |
1,978
-78
| -4% | -$36.3K | 0.06% | 253 |
|
|
2024
Q2 | $963K | Buy |
2,056
+73
| +4% | +$34.2K | 0.06% | 256 |
|
|
2024
Q1 | $829K | Buy |
1,983
+51
| +3% | +$21.3K | 0.06% | 270 |
|
|
2023
Q4 | $786K | Buy |
1,932
+797
| +70% | +$324K | 0.06% | 257 |
|
|
2023
Q3 | $395K | Sell |
1,135
-27
| -2% | -$9.39K | 0.03% | 336 |
|
|
2023
Q2 | $409K | Buy |
1,162
+145
| +14% | +$51K | 0.03% | 329 |
|
|
2023
Q1 | $320K | Sell |
1,017
-3,970
| -80% | -$1.25M | 0.03% | 372 |
|
|
2022
Q4 | $1.44M | Sell |
4,987
-704
| -12% | -$203K | 0.14% | 151 |
|
|
2022
Q3 | $1.65M | Buy |
5,691
+462
| +9% | +$134K | 0.17% | 133 |
|
|
2022
Q2 | $1.47M | Buy |
5,229
+2,268
| +77% | +$639K | 0.15% | 138 |
|
|
2022
Q1 | $773K | Buy |
2,961
+1,083
| +58% | +$283K | 0.07% | 251 |
|
|
2021
Q4 | $412K | Buy |
1,878
+17
| +0.9% | +$3.73K | 0.04% | 362 |
|
|
2021
Q3 | $338K | Buy |
1,861
+172
| +10% | +$31.2K | 0.03% | 395 |
|
|
2021
Q2 | $341K | Buy |
+1,689
| New | +$341K | 0.03% | 384 |
|
|
2021
Q1 | – | Sell |
-1,051
| Closed | -$248K | – | 419 |
|
|
2020
Q4 | $248K | Buy |
+1,051
| New | +$248K | 0.03% | 401 |
|
|
2020
Q3 | – | Sell |
-1,279
| Closed | -$371K | – | 292 |
|
|
2020
Q2 | $371K | Buy |
+1,279
| New | +$371K | 0.07% | 210 |
|
|
2020
Q1 | – | Sell |
-1,602
| Closed | -$351K | – | 301 |
|
|
2019
Q4 | $351K | Buy |
+1,602
| New | +$351K | 0.06% | 242 |
|